European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

European equities traded in the US as American depositary receipts were higher late Friday morning, rising 0.53% to 1,446.18 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies (DBVT) and Grifols (GRFS), which climbed 6.6% and 5.7% respectively. They were followed by biopharmaceutical company Genfit (GNFT) and pharmaceutical company Novo Nordisk (NVO), which increased 3.5% and 1.9% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and petroleum refiner Equinor (EQNR), which fell 1.4% and 1.2% respectively. They were followed by biopharmaceutical company Calliditas Therapeutics (CALT) and furniture maker Natuzzi (NTZ), which were off 0.8% each.

From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and medical device maker Smith & Nephew (SNN), which rose 8.8% and 7.3% respectively. They were followed by biopharmaceutical company Amarin (AMRN) and financial services company Lloyds Banking Group (LYG), which rose 4.8% and 3.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm (TCBP) and insurance firm Prudential (PUK), which fell 7.4% and 2.3% respectively. They were followed by cruise line operator Carnival (CUK) and hospitality company InterContinental Hotels Group (IHG), which were down 2.2% and 1.5% respectively.